Several human tumor tissues, such as human pancreatic cancer [12], breast cancer [13], chronic lymphocytic leukemia [14], colorectal cancer [15, 16] and non-small cell lung cancer [17], have decreased expression of Bax protein which is significantly associated with poor clinical outcomes of these cancers. Here, BAX is linked to cancer.